Treatment of infections caused by carbapenemase-producing Enterobacterales. Scientific Publication

Oct 1, 2022 | Magazine: Revista Española de Quimioterapia

M Íñigo, J L Del Pozo 1

Abstract

Antibiotic resistance is one of the main menaces to public and individual health worldwide. In the last two decades, an increase in the detection of carbapenem-resistant Enterobacterales has been reported.

The treatment of infections caused by these strains is a therapeutic challenge. The use of carbapenems may be beneficial depending on MIC value and source of infection.

New drugs, with different activity against the different classes of carbapenemases, are developed showing significant benefits.

CITATION Rev Esp Quimioter. 2022 Oct;35 Suppl 3:46-50. doi: 10.37201/req/s03.11.2022. Epub 2022 Oct 24.

see publication in pubmed

Our authors

Imagen de la Dra. Melania Iñigo. Microbióloga. Clínica Universidad de Navarra

Dr. Melania Iñigo Pestaña [SP] Curriculum

Specialist Clinical Microbiology Department

Madrid headquarters

Imagen del Dr. José Luis del Pozo León, especialista en Microbiología Clínica de la Clínica Universidad de Navarra.

Dr. José Luis del Pozo León [SP] Curriculum

Director Infectious Diseases Service

Navarre headquarters